Founder of NeuroDerm Ltd., Amir Reichman is Chief Executive Officer & Director at BiondVax Pharmaceuticals Ltd.

In his past career he was Head-Global Vaccines Value Chain Management at Novartis Vaccines & Diagnostics, Inc. (North Carolina), Chief Engineer & Senior Scientist at NeuroDerm Ltd. and Head-Global Vaccines Engineering Core Technology at GlaxoSmithKline Pharmaceuticals SA (Belgium).

He received an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Ben-Gurion University of the Negev.